The Sirtex chair (funded by Sirtex Medical Limited) will be held by Professor Ross Stephens will focus on research into localised cancer treatments.
Sirtex has made a commitment to sponsor the Chair for a total of up to three million dollars over three years.
ANU Vice-Chancellor Professor Ian Young AO, welcomed the establishment of the Chair.
“This is a fine example of industry investing in a meaningful way in research and development for the benefit of all. It shows the confidence that Sirtex has for the quality and quantity of research that ANU produces.”
The research aims to create a technology that will stop the collateral damage of healthy cells in cancer patients by localising the radiation treatment at tumour sites.
“We’re trying to fashion an internal therapy that is highly localised and that also gives doctors flexibility in designing individual treatment plans.”
“This support is providing an excellent collaboration between university and industry. And we all get the satisfaction of knowing that the science we’re doing has the potential to really help people,” says Professor Stephens.